Select Medical Holdings Corporation Announces Stellar Second Quarter Results
Select Medical Holdings Corporation (NYSE: SEM) recently reported exciting fiscal results for its second quarter. The company revealed a commendable 4.5% increase in revenue, marking a rise to $1,339.6 million compared to last year’s figures. This growth is a testament to Select Medical's robust operating strategy and commitment to patient care.
Financial Performance Overview
During the second quarter, income from continuing operations before other income and expense showcased a healthy increase of 17.2%, totaling $86.5 million. Additionally, select medical recorded an impressive 53.8% rise in income from continuing operations net of tax, reaching $57.9 million. Encouragingly, earnings per common share soared by 88.2%, climbing to $0.32, a clear boost compared to $0.17 from the same quarter in 2024.
Half-Year Review
Reviewing the first half of the fiscal year, Select Medical’s revenue saw an increase of 3.4%, totaling $2,692.8 million. The organization also announced a 33.7% rise in income from continuing operations, net of tax, reaching $132.6 million. Adjusted EBITDA for this period was consistent at $276.9 million, indicating stable operational performance despite market fluctuations during this timeframe.
Impact of Concentra Separation
The completion of the Concentra Group Holdings Parent, Inc. spin-off last fall, which involved distributing shares to stockholders, allows Select Medical to focus on expanding its core hospital segments. The absence of Concentra’s operations is now reflected as discontinued, with even greater expectations for income from continuing operations moving forward.
Strategic Business Segments
Focusing on the distinct segments, the critical illness recovery hospital segment witnessed a slight decrease in revenue to $601.1 million. The adjusted EBITDA margin, however, stands robust at 9.4%. Conversely, the rehabilitation hospital segment experienced impressive growth, with a 17.2% increase in revenue totaling $313.8 million and maintaining a strong EBITDA margin of 22.6%. The outpatient rehabilitation clinics also reported a 3.8% revenue increase, reaching $327.6 million.
Dividend Declaration and Future Vision
On July 30, the Board of Directors of Select Medical declared a quarterly cash dividend of $0.0625 per share, scheduled for distribution to shareholders. The decision for future dividends will depend on several factors, including financial performance and liquidity needs.
Market Outlook and Conference Call
Select Medical has reaffirmed its business outlook for the remainder of the fiscal year, projecting revenues between $5.3 billion and $5.5 billion. A conference call is scheduled for August 1, 2025, aimed at discussing these results and future strategies.
Investing in the Future
The authorized $1.0 billion stock repurchase program indicates the company’s confidence in its value and growth trajectory. With active repurchases already underway, Select Medical is strategically positioned to optimize its capital structure while providing shareholder returns.
Frequently Asked Questions
What were the total revenues for Select Medical in Q2 2025?
The total revenues for Select Medical in Q2 2025 were $1,339.6 million, reflecting a 4.5% increase compared to the previous year.
What percentage increase was observed in earnings per share?
Earnings per share increased by an impressive 88.2% to reach $0.32 in Q2 2025.
How did the income from continuing operations change?
The income from continuing operations net of tax rose by 53.8%, showing robust growth to $57.9 million.
What is the projected revenue range for the full year 2025?
Select Medical expects revenue to be in the range of $5.3 billion to $5.5 billion for the full year of 2025.
When will the dividend be paid?
The declared cash dividend will be payable on or about August 28, 2025, to stockholders of record as of August 13, 2025.
